| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| Toripalimab | 特瑞普利单抗 | 1924598-82-2 |
| Ivuxolimab | IVUXOLIMAB (艾沃利单抗 ) | 2225940-98-5 |
| Sasanlimab | SASANLIMAB (萨善利单抗 ) | 2206792-50-7 |
| Tavolimab | Tavolimab | 1635395-25-3 |
| Tucotuzumab Celmoleukin | Tucotuzumab Celmoleukin | 339986-90-2 |
| Vapaliximab | VAPALIXIMAB ( 伐利昔单抗 ) | 336801-86-6 |
| Sifalimumab | SIFALIMUMAB ( 西法木单抗 ) | 1006877-41-3 |
| Enokizumab | ENOKIZUMAB ( 依诺凯组单抗 ) | 909875-08-7 |
| Onartuzumab | ONARTUZUMAB ( 奥那妥组单抗 ) | 1133766-06-9 |
| Indatuximab Ravtansine | Indatuximab Ravtansine | 1238517-16-2 |
| Quilizumab | Quilizumab | 1228538-47-3 |
| Placulumab | Placulumab | 945781-29-3 |
| Concizumab | Concizumab | 1312299-39-0 |
| Tarextumab | Tarextumab | 1359940-55-8 |
| Anifrolumab | Anifrolumab | 1326232-46-5 |
| Emibetuzumab | Emibetuzumab | 1365287-97-3 |
| Lumretuzumab | Lumretuzumab | 1448327-63-6 |
| Tesidolumab | Tesidolumab | 1531594-08-7 |
| Lilotomab | Lilotomab | 1453362-55-4 |
| Ascrinvacumab | Ascrinvacumab | 1463459-96-2 |
